Document is current
Any future updates will be listed below
-
Authors
Zhang, Ze https://orcid.org/0000-0001-9854-5823
Wiencke, John K.
Kelsey, Karl T.
Koestler, Devin C.
Christensen, Brock C.
Salas, Lucas A.
-
Funding
Funding for this research was provided by:
NIH (R01CA216265, R01CA253976, R01 CA207360, P50 CA097257)
AACR (18‐90‐52‐MICH)
Congressionally Directed Medical Research Programs (W81XWH-20-1-0778)
National Institute of General Medical Sciences (P20GM104416/8299, P20GM103428)
National Institute of General Medical Sciences (P30 CA168524, P20 GM130423)
Magnin Newman Endowment for Neuro-oncology
- License Information
-
More Information
Article History
Received: 11 September 2022
Accepted: 30 October 2022
First Online: 8 November 2022
Declarations
:
: Immune cells used in the experiments were obtained commercially. All donors are anonymous and provided written informed consent before donation to the commercial companies. Other samples are from publicly available data source. Ethics approval and consent can be found in the original papers.
: The final version of the manuscript has been reviewed and approved by all authors.
: Drs. Kelsey and Wiencke are founders of Cellintec, which had no role in this research.
